Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$0.7 - $1.58 $24,149 - $54,508
-34,499 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$0.71 - $4.04 $24,494 - $139,375
34,499 New
34,499 $53,000

Others Institutions Holding VTVT

# of Institutions
1
Shares Held
243K
Call Options Held
0
Put Options Held
0

About vTv Therapeutics Inc.


  • Ticker VTVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,483,600
  • Market Cap $1.42B
  • Description
  • vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...
More about VTVT
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.